Trenbolone Hexahydrobenzyl Carbonate Injection

Trenbolone Hexahydrobenzyl Carbonate Injection

  • Packing: 1 Ml Ampoule, 1.5 Ml Ampoule, 10 Ml Vial, 1 Ml PFS, 1.5 Ml PFS
  • Available Strength : 76.5 Mg/1.5 Ml

Description

Product Description: Trenbolone Hexahydrobenzyl Carbonate Injection is a sterile solution containing trenbolone hexahydrobenzyl carbonate, a synthetic anabolic steroid derived from nandrolone. It is formulated for intramuscular administration and is commonly used to promote muscle growth and enhance physical performance.

Indications and Usage: Trenbolone Hexahydrobenzyl Carbonate Injection is indicated for the management of conditions characterized by muscle wasting, such as cachexia and osteoporosis. It is also used off-label to improve muscle mass and strength in athletes and bodybuilders.

Dosage and Administration: The dosage of Trenbolone Hexahydrobenzyl Carbonate Injection varies depending on the individual's response to treatment, the severity of the condition being treated, and other factors. It is typically administered by intramuscular injection at a dosage ranging from 75 mg to 100 mg every 1 to 2 weeks. Dosing frequency may be adjusted based on individual response and tolerance.

Dosage Forms and Strengths: Trenbolone Hexahydrobenzyl Carbonate Injection is available as a sterile solution in vials. The solution is typically supplied in concentrations of 75 mg/mL.

Contraindications: Trenbolone Hexahydrobenzyl Carbonate Injection is contraindicated in patients with a known hypersensitivity to trenbolone hexahydrobenzyl carbonate or any component of the formulation. It is also contraindicated in patients with prostate or breast cancer, hypercalcemia, and severe hepatic impairment.

Warnings and Precautions: Before initiating treatment with Trenbolone Hexahydrobenzyl Carbonate Injection, healthcare providers should assess patients for contraindications and preexisting conditions, including cardiovascular disease, hepatic dysfunction, and renal impairment. Prolonged use may increase the risk of liver damage, cardiovascular events, and psychiatric disorders.

Adverse Reactions/Side Effects: Common adverse reactions associated with Trenbolone Hexahydrobenzyl Carbonate Injection include hepatic dysfunction, cardiovascular effects, and psychiatric disturbances. Other potential side effects may include virilization in females, gynecomastia in males, and fluid retention.

Drug Interactions: Trenbolone Hexahydrobenzyl Carbonate Injection may interact with certain medications, including anticoagulants, insulin, and corticosteroids. Concomitant use with other hepatotoxic agents may increase the risk of liver damage.

Use In Specific Populations Description: Trenbolone Hexahydrobenzyl Carbonate Injection should be used with caution in pregnant and lactating women due to potential virilizing effects on the fetus or neonate. It is not recommended for use in pediatric patients, as safety and efficacy have not been established in this population.

How Supplied/Storage and Handling: Trenbolone Hexahydrobenzyl Carbonate Injection is supplied as a sterile solution in vials. It should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), protected from light and moisture. Unused portions should be discarded according to local regulations for biohazardous waste disposal.